Serum carnosinase activities in central nervous system disorders.
暂无分享,去创建一个
R. Sherwood | T. Peters | W. Wassif | N. Leigh | B. Summers | A. Amir | B. Idowu | Timothy J. Peters | Roy Sherwood | Bernadine D. Idowu | Beatrice A. Summers
[1] L. Mosovich,et al. Serum Carnosinase Deficiency Concomitant with Mental Retardation , 1973, Pediatric Research.
[2] W. Gibb,et al. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[3] M. Swash,et al. Motor neuron disease. , 1992, Postgraduate medical journal.
[4] J. Berstad,et al. HOMOCARNOSINOSIS. 2. A FAMILIAL METABOLIC DISORDER ASSOCIATED WITH SPASTIC PARAPLEGIA, PROGRESSIVE MENTAL DEFICIENCY, and RETINAL PIGMENTATION , 1976, Acta neurologica Scandinavica.
[5] S. Kish,et al. HOMOCARNOSINOSIS: INCREASED CONTENT OF HOMOCARNOSINE AND DEFICIENCY OF HOMOCARNOSINASE IN BRAIN , 1979, Journal of neurochemistry.
[6] J. Lenney,et al. Homocarnosinosis: lack of serum carnosinase is the defect probably responsible for elevated brain and CSF homocarnosine. , 1983, Clinica chimica acta; international journal of clinical chemistry.
[7] P. Duane,et al. The Relationship between Serum Carnosinase Activity and Severity of Liver Failure in Patients with Alcoholic and Primary Biliary Cirrhosis , 1991 .
[8] F. Margolis. Carnosine in the Primary Olfactory Pathway , 1974, Science.
[9] K. Miyai,et al. Fluorometric Assay of Human Serum Carnosinase Activity in Normal Children, Adults and Patients with Myopathy , 1984, Annals of clinical biochemistry.
[10] L. Gjessing,et al. HOMOCARNOSINOSIS: A NEW METABOLIC DISORDER ASSOCIATED WITH SPASTICITY AND MENTAL RETARDATION , 1974 .
[11] M. Jackson,et al. Homocarnosinosis patients and great apes have a serum protein that cross-reacts with human serum carnosinase. , 1992, Clinica chimica acta; international journal of clinical chemistry.
[12] M. Jackson,et al. Purification and properties of human serum carnosinase. , 1991, Clinica chimica acta; international journal of clinical chemistry.
[13] V. Preedy,et al. Clinical Studies of the Post-Viral Fatigue Syndrome (PVFS) with Special Reference to Skeletal Muscle Function , 1988 .
[14] S. Kish,et al. REGIONAL DISTRIBUTION OF HOMOCARNOSINE, HOMOCARNOSINE‐CARNOSINE SYNTHETASE AND HOMOCARNOSINASE IN HUMAN BRAIN , 1979, Journal of neurochemistry.
[15] J. Aldstadt,et al. Effects of carnosine and anserine on muscle and non-muscle phosphorylases. , 1984, Comparative biochemistry and physiology. B, Comparative biochemistry.
[16] T. Peters,et al. Serum carnosinase activities in patients with alcoholic chronic skeletal muscle myopathy. , 1988, Clinical science.
[17] P. W. Chan,et al. Human serum carnosinase: characterization, distinction from cellular carnosinase, and activation by cadmium. , 1982, Clinica chimica acta; international journal of clinical chemistry.
[18] V. Preedy,et al. The relationship between muscle fibre atrophy factor, plasma carnosinase activities and muscle RNA and protein composition in chronic alcoholic myopathy. , 1993, Alcohol and alcoholism.
[19] T. Perry,et al. Carnosinemia. A new metabolic disorder associated with neurologic disease and mental defect. , 1967, The New England journal of medicine.
[20] H. Schlüter,et al. Effect of plasma from patients with essential hypertension on vascular resistance in the isolated perfused rat kidney. , 1991, Clinical science.